Oxford COVID vaccine trial results called “extremely encouraging”

Read MoreAstraZeneca says the trial data “increases our confidence that the vaccine will work and allows us to continue our plans to manufacture the vaccine at scale.”AstraZeneca says the trial data “increases our confidence that the vaccine will work and allows us to continue our plans to manufacture the vaccine at scale.”